Moderate riskFDA DrugClass II

Apollo Care semaglutide injection recalled for particulate matter contamination

Apollo Care's semaglutide injectable medication (a weight-loss drug) contains small particles of nylon and silk-like material in some vials. The affected lots were distributed nationwide. No injuries have been reported.

From the FDA notice · Read the official notice ↗

What to do

  1. Check your semaglutide vial for lot number and expiration date
  2. If you have a vial from lot AC-017125 (exp. 8/30/2026) or lots AC-017138, AC-017147, AC-017214, AC-017226, or AC-017228 (exp. 12/31/2026), do not use it
  3. Contact your pharmacy or prescriber for a replacement vial
  4. If you have already injected from an affected vial, consult your doctor

Is yours affected?

Compare your label or packaging with the recalled product.

Product
SEMAGLUTIDE 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-822-02
Sold in
Nationwide
Made for
Adults (0 months and older)

This recall covers 11 products — see all of them.

Details

Units affected
24,608 vials.
Illnesses reported
None reported
Manufactured in
3801 Mojave Ct Ste 101, Columbia, MO, United States
Classification
Class II
Recall number
D-0751-2026

In the FDA's words

Description
SEMAGLUTIDE 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-822-02 Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material Lot: AC-017125, Exp. 8/30/2026; AC-017138, AC-017147, AC-017214, AC-017226, AC-017228, Exp. 12/31/2026. Distribution: Nationwide within the U.S Affected quantity: 24,608 vials.
Hazard
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

11 products in this recall

Apollo Care semaglutide vials recalled for particulate matter

Apollo Care is recalling 11 strengths of semaglutide sterile multi-dose vials for subcutaneous injection, all sold under the APOLLO care brand. The vials may contain particles identified as nylon/polyamide and silk-like material. The recall covers products distributed nationwide, and no injuries have been reported.

The agency lists each product separately. Check every one you might have.

Related topics

ParticulateDrugsSold nationwideMore from FDA Drug